nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR1B—trigeminal nucleus—multiple sclerosis	0.0386	0.139	CbGeAlD
Asenapine—HTR1D—trigeminal nucleus—multiple sclerosis	0.0374	0.135	CbGeAlD
Asenapine—CYP2D6—Fingolimod—multiple sclerosis	0.037	0.261	CbGbCtD
Asenapine—HTR1D—meninx—multiple sclerosis	0.0248	0.0894	CbGeAlD
Asenapine—CYP3A4—Fingolimod—multiple sclerosis	0.0235	0.166	CbGbCtD
Asenapine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0186	0.0669	CbGeAlD
Asenapine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0152	0.107	CbGbCtD
Asenapine—CYP3A4—Triamcinolone—multiple sclerosis	0.0115	0.0811	CbGbCtD
Asenapine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0111	0.078	CbGbCtD
Asenapine—HTR1B—trigeminal nerve—multiple sclerosis	0.0101	0.0366	CbGeAlD
Asenapine—CYP3A4—Betamethasone—multiple sclerosis	0.00985	0.0696	CbGbCtD
Asenapine—HTR1D—trigeminal nerve—multiple sclerosis	0.00982	0.0354	CbGeAlD
Asenapine—CYP3A4—Prednisolone—multiple sclerosis	0.00972	0.0686	CbGbCtD
Asenapine—CYP3A4—Prednisone—multiple sclerosis	0.00918	0.0648	CbGbCtD
Asenapine—CYP2D6—Dexamethasone—multiple sclerosis	0.00901	0.0636	CbGbCtD
Asenapine—CYP3A4—Dexamethasone—multiple sclerosis	0.00573	0.0405	CbGbCtD
Asenapine—HTR7—pons—multiple sclerosis	0.00551	0.0199	CbGeAlD
Asenapine—HTR2A—trigeminal nerve—multiple sclerosis	0.00488	0.0176	CbGeAlD
Asenapine—DRD1—nerve—multiple sclerosis	0.00457	0.0165	CbGeAlD
Asenapine—HTR5A—nervous system—multiple sclerosis	0.00413	0.0149	CbGeAlD
Asenapine—HTR5A—central nervous system—multiple sclerosis	0.00397	0.0143	CbGeAlD
Asenapine—HTR7—peripheral nervous system—multiple sclerosis	0.00366	0.0132	CbGeAlD
Asenapine—HTR2A—pons—multiple sclerosis	0.00343	0.0124	CbGeAlD
Asenapine—HTR1E—brainstem—multiple sclerosis	0.00336	0.0121	CbGeAlD
Asenapine—HTR5A—brain—multiple sclerosis	0.00315	0.0114	CbGeAlD
Asenapine—HTR7—nerve—multiple sclerosis	0.00286	0.0103	CbGeAlD
Asenapine—DRD2—nerve—multiple sclerosis	0.0027	0.00973	CbGeAlD
Asenapine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00269	0.00969	CbGeAlD
Asenapine—HTR2A—pineal body—multiple sclerosis	0.00245	0.00884	CbGeAlD
Asenapine—HTR2A—peripheral nervous system—multiple sclerosis	0.00228	0.00824	CbGeAlD
Asenapine—DRD1—brainstem—multiple sclerosis	0.00196	0.00707	CbGeAlD
Asenapine—HTR2A—nerve—multiple sclerosis	0.00178	0.00642	CbGeAlD
Asenapine—HTR1E—nervous system—multiple sclerosis	0.00176	0.00635	CbGeAlD
Asenapine—HTR1E—central nervous system—multiple sclerosis	0.0017	0.00611	CbGeAlD
Asenapine—HTR1B—brainstem—multiple sclerosis	0.00159	0.00573	CbGeAlD
Asenapine—DRD4—brain—multiple sclerosis	0.00156	0.00563	CbGeAlD
Asenapine—HTR1D—brainstem—multiple sclerosis	0.00154	0.00555	CbGeAlD
Asenapine—HTR2C—brainstem—multiple sclerosis	0.00152	0.00549	CbGeAlD
Asenapine—SLC6A4—brainstem—multiple sclerosis	0.00144	0.00521	CbGeAlD
Asenapine—DRD3—nervous system—multiple sclerosis	0.00144	0.00518	CbGeAlD
Asenapine—DRD3—central nervous system—multiple sclerosis	0.00138	0.00498	CbGeAlD
Asenapine—HTR6—nervous system—multiple sclerosis	0.00138	0.00498	CbGeAlD
Asenapine—HTR1E—brain—multiple sclerosis	0.00135	0.00485	CbGeAlD
Asenapine—HTR6—central nervous system—multiple sclerosis	0.00133	0.0048	CbGeAlD
Asenapine—HTR1A—brainstem—multiple sclerosis	0.00128	0.00462	CbGeAlD
Asenapine—HRH2—nervous system—multiple sclerosis	0.00126	0.00455	CbGeAlD
Asenapine—DRD1—midbrain—multiple sclerosis	0.00125	0.00451	CbGeAlD
Asenapine—HTR7—brainstem—multiple sclerosis	0.00123	0.00442	CbGeAlD
Asenapine—HRH2—central nervous system—multiple sclerosis	0.00122	0.00438	CbGeAlD
Asenapine—ADRA1A—brainstem—multiple sclerosis	0.00118	0.00426	CbGeAlD
Asenapine—DRD2—brainstem—multiple sclerosis	0.00116	0.00418	CbGeAlD
Asenapine—DRD2—retina—multiple sclerosis	0.00112	0.00403	CbGeAlD
Asenapine—DRD3—brain—multiple sclerosis	0.0011	0.00396	CbGeAlD
Asenapine—HTR2C—medulla oblongata—multiple sclerosis	0.00106	0.00383	CbGeAlD
Asenapine—HTR6—brain—multiple sclerosis	0.00106	0.00381	CbGeAlD
Asenapine—DRD1—nervous system—multiple sclerosis	0.00103	0.00371	CbGeAlD
Asenapine—HTR1B—midbrain—multiple sclerosis	0.00101	0.00365	CbGeAlD
Asenapine—DRD1—central nervous system—multiple sclerosis	0.00099	0.00357	CbGeAlD
Asenapine—HTR1B—spinal cord—multiple sclerosis	0.000988	0.00356	CbGeAlD
Asenapine—HTR1D—midbrain—multiple sclerosis	0.000981	0.00354	CbGeAlD
Asenapine—HTR2C—midbrain—multiple sclerosis	0.000971	0.0035	CbGeAlD
Asenapine—HRH2—brain—multiple sclerosis	0.000966	0.00348	CbGeAlD
Asenapine—HTR2C—spinal cord—multiple sclerosis	0.000948	0.00342	CbGeAlD
Asenapine—SLC6A4—midbrain—multiple sclerosis	0.000921	0.00332	CbGeAlD
Asenapine—SLC6A4—spinal cord—multiple sclerosis	0.000898	0.00324	CbGeAlD
Asenapine—HTR7—medulla oblongata—multiple sclerosis	0.000855	0.00308	CbGeAlD
Asenapine—HTR1B—nervous system—multiple sclerosis	0.000833	0.003	CbGeAlD
Asenapine—HTR1A—midbrain—multiple sclerosis	0.000818	0.00295	CbGeAlD
Asenapine—HTR1D—nervous system—multiple sclerosis	0.000806	0.00291	CbGeAlD
Asenapine—HTR1B—central nervous system—multiple sclerosis	0.000802	0.00289	CbGeAlD
Asenapine—HTR2C—nervous system—multiple sclerosis	0.000798	0.00288	CbGeAlD
Asenapine—HTR1A—spinal cord—multiple sclerosis	0.000798	0.00288	CbGeAlD
Asenapine—ADRA2C—medulla oblongata—multiple sclerosis	0.000786	0.00283	CbGeAlD
Asenapine—DRD1—brain—multiple sclerosis	0.000786	0.00283	CbGeAlD
Asenapine—ADRB1—nervous system—multiple sclerosis	0.000784	0.00282	CbGeAlD
Asenapine—HTR7—midbrain—multiple sclerosis	0.000781	0.00282	CbGeAlD
Asenapine—HTR1D—central nervous system—multiple sclerosis	0.000776	0.0028	CbGeAlD
Asenapine—HTR2C—central nervous system—multiple sclerosis	0.000769	0.00277	CbGeAlD
Asenapine—HTR2A—brainstem—multiple sclerosis	0.000765	0.00276	CbGeAlD
Asenapine—HTR7—spinal cord—multiple sclerosis	0.000762	0.00275	CbGeAlD
Asenapine—SLC6A4—nervous system—multiple sclerosis	0.000757	0.00273	CbGeAlD
Asenapine—ADRB1—central nervous system—multiple sclerosis	0.000754	0.00272	CbGeAlD
Asenapine—HTR2B—nervous system—multiple sclerosis	0.00075	0.0027	CbGeAlD
Asenapine—DRD2—midbrain—multiple sclerosis	0.000739	0.00266	CbGeAlD
Asenapine—HTR2A—retina—multiple sclerosis	0.000738	0.00266	CbGeAlD
Asenapine—SLC6A4—central nervous system—multiple sclerosis	0.000729	0.00263	CbGeAlD
Asenapine—HTR2B—central nervous system—multiple sclerosis	0.000722	0.0026	CbGeAlD
Asenapine—ADRA2C—midbrain—multiple sclerosis	0.000718	0.00259	CbGeAlD
Asenapine—ADRA2C—spinal cord—multiple sclerosis	0.000701	0.00253	CbGeAlD
Asenapine—CYP2D6—brainstem—multiple sclerosis	0.000696	0.00251	CbGeAlD
Asenapine—HTR1A—nervous system—multiple sclerosis	0.000672	0.00242	CbGeAlD
Asenapine—HTR1A—central nervous system—multiple sclerosis	0.000647	0.00233	CbGeAlD
Asenapine—HTR7—nervous system—multiple sclerosis	0.000642	0.00232	CbGeAlD
Asenapine—HTR1B—brain—multiple sclerosis	0.000637	0.00229	CbGeAlD
Asenapine—HTR1A—cerebellum—multiple sclerosis	0.000632	0.00228	CbGeAlD
Asenapine—ADRA2A—medulla oblongata—multiple sclerosis	0.000627	0.00226	CbGeAlD
Asenapine—ADRA1A—nervous system—multiple sclerosis	0.00062	0.00223	CbGeAlD
Asenapine—HTR7—central nervous system—multiple sclerosis	0.000618	0.00223	CbGeAlD
Asenapine—HTR1D—brain—multiple sclerosis	0.000616	0.00222	CbGeAlD
Asenapine—HTR2C—brain—multiple sclerosis	0.00061	0.0022	CbGeAlD
Asenapine—DRD2—nervous system—multiple sclerosis	0.000607	0.00219	CbGeAlD
Asenapine—HTR7—cerebellum—multiple sclerosis	0.000604	0.00218	CbGeAlD
Asenapine—ADRB1—brain—multiple sclerosis	0.000599	0.00216	CbGeAlD
Asenapine—ADRA1A—central nervous system—multiple sclerosis	0.000596	0.00215	CbGeAlD
Asenapine—ADRA2C—nervous system—multiple sclerosis	0.00059	0.00213	CbGeAlD
Asenapine—DRD2—central nervous system—multiple sclerosis	0.000585	0.00211	CbGeAlD
Asenapine—ADRA1A—cerebellum—multiple sclerosis	0.000583	0.0021	CbGeAlD
Asenapine—Malaise—Mitoxantrone—multiple sclerosis	0.000581	0.00186	CcSEcCtD
Asenapine—SLC6A4—brain—multiple sclerosis	0.000579	0.00209	CbGeAlD
Asenapine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000577	0.00185	CcSEcCtD
Asenapine—Weight increased—Betamethasone—multiple sclerosis	0.000576	0.00185	CcSEcCtD
Asenapine—Weight increased—Dexamethasone—multiple sclerosis	0.000576	0.00185	CcSEcCtD
Asenapine—Asthenia—Cladribine—multiple sclerosis	0.000574	0.00184	CcSEcCtD
Asenapine—HTR2B—brain—multiple sclerosis	0.000573	0.00207	CbGeAlD
Asenapine—ADRA2A—midbrain—multiple sclerosis	0.000573	0.00207	CbGeAlD
Asenapine—DRD2—cerebellum—multiple sclerosis	0.000571	0.00206	CbGeAlD
Asenapine—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000571	0.00183	CcSEcCtD
Asenapine—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000571	0.00183	CcSEcCtD
Asenapine—ADRA2C—central nervous system—multiple sclerosis	0.000568	0.00205	CbGeAlD
Asenapine—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000563	0.0018	CcSEcCtD
Asenapine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000562	0.0018	CcSEcCtD
Asenapine—ADRA2A—spinal cord—multiple sclerosis	0.000559	0.00202	CbGeAlD
Asenapine—Convulsion—Mitoxantrone—multiple sclerosis	0.000558	0.00179	CcSEcCtD
Asenapine—Hypertension—Mitoxantrone—multiple sclerosis	0.000556	0.00178	CcSEcCtD
Asenapine—ADRA2C—cerebellum—multiple sclerosis	0.000556	0.002	CbGeAlD
Asenapine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000551	0.00177	CcSEcCtD
Asenapine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000549	0.00176	CcSEcCtD
Asenapine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000548	0.00176	CcSEcCtD
Asenapine—Anxiety—Mitoxantrone—multiple sclerosis	0.000547	0.00175	CcSEcCtD
Asenapine—Osteoarthritis—Methotrexate—multiple sclerosis	0.000533	0.00171	CcSEcCtD
Asenapine—HTR2A—medulla oblongata—multiple sclerosis	0.000533	0.00192	CbGeAlD
Asenapine—Dizziness—Cladribine—multiple sclerosis	0.000529	0.0017	CcSEcCtD
Asenapine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000526	0.00169	CcSEcCtD
Asenapine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000521	0.00167	CcSEcCtD
Asenapine—Shock—Mitoxantrone—multiple sclerosis	0.000517	0.00166	CcSEcCtD
Asenapine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000517	0.00166	CcSEcCtD
Asenapine—Neutropenia—Prednisone—multiple sclerosis	0.000516	0.00165	CcSEcCtD
Asenapine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000515	0.00165	CcSEcCtD
Asenapine—HTR1A—brain—multiple sclerosis	0.000514	0.00185	CbGeAlD
Asenapine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000513	0.00165	CcSEcCtD
Asenapine—Irritability—Methotrexate—multiple sclerosis	0.000509	0.00163	CcSEcCtD
Asenapine—Vomiting—Cladribine—multiple sclerosis	0.000509	0.00163	CcSEcCtD
Asenapine—Angiopathy—Methylprednisolone—multiple sclerosis	0.000506	0.00162	CcSEcCtD
Asenapine—Rash—Cladribine—multiple sclerosis	0.000505	0.00162	CcSEcCtD
Asenapine—Dermatitis—Cladribine—multiple sclerosis	0.000504	0.00162	CcSEcCtD
Asenapine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000503	0.00161	CcSEcCtD
Asenapine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000502	0.00161	CcSEcCtD
Asenapine—Weight increased—Prednisone—multiple sclerosis	0.000502	0.00161	CcSEcCtD
Asenapine—Headache—Cladribine—multiple sclerosis	0.000501	0.00161	CcSEcCtD
Asenapine—Hyperglycaemia—Prednisone—multiple sclerosis	0.000497	0.0016	CcSEcCtD
Asenapine—Hypotension—Mitoxantrone—multiple sclerosis	0.000491	0.00158	CcSEcCtD
Asenapine—HTR7—brain—multiple sclerosis	0.000491	0.00177	CbGeAlD
Asenapine—Depression—Prednisone—multiple sclerosis	0.00049	0.00157	CcSEcCtD
Asenapine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000488	0.00157	CcSEcCtD
Asenapine—HTR2A—midbrain—multiple sclerosis	0.000487	0.00176	CbGeAlD
Asenapine—Malnutrition—Methylprednisolone—multiple sclerosis	0.000485	0.00156	CcSEcCtD
Asenapine—Angioedema—Prednisolone—multiple sclerosis	0.000483	0.00155	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—multiple sclerosis	0.000482	0.00155	CcSEcCtD
Asenapine—HRH1—nervous system—multiple sclerosis	0.00048	0.00173	CbGeAlD
Asenapine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000479	0.00154	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000479	0.00154	CcSEcCtD
Asenapine—Malaise—Prednisolone—multiple sclerosis	0.000477	0.00153	CcSEcCtD
Asenapine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000476	0.00153	CcSEcCtD
Asenapine—HTR2A—spinal cord—multiple sclerosis	0.000475	0.00171	CbGeAlD
Asenapine—Nausea—Cladribine—multiple sclerosis	0.000475	0.00152	CcSEcCtD
Asenapine—Syncope—Prednisolone—multiple sclerosis	0.000474	0.00152	CcSEcCtD
Asenapine—Eye disorder—Dexamethasone—multiple sclerosis	0.000474	0.00152	CcSEcCtD
Asenapine—Eye disorder—Betamethasone—multiple sclerosis	0.000474	0.00152	CcSEcCtD
Asenapine—ADRA1A—brain—multiple sclerosis	0.000474	0.00171	CbGeAlD
Asenapine—ADRA2A—nervous system—multiple sclerosis	0.000471	0.0017	CbGeAlD
Asenapine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000469	0.0015	CcSEcCtD
Asenapine—Somnolence—Mitoxantrone—multiple sclerosis	0.000468	0.0015	CcSEcCtD
Asenapine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000465	0.00149	CcSEcCtD
Asenapine—DRD2—brain—multiple sclerosis	0.000464	0.00167	CbGeAlD
Asenapine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000463	0.00149	CcSEcCtD
Asenapine—HRH1—central nervous system—multiple sclerosis	0.000462	0.00166	CbGeAlD
Asenapine—Angiopathy—Dexamethasone—multiple sclerosis	0.00046	0.00147	CcSEcCtD
Asenapine—Angiopathy—Betamethasone—multiple sclerosis	0.00046	0.00147	CcSEcCtD
Asenapine—Convulsion—Prednisolone—multiple sclerosis	0.000458	0.00147	CcSEcCtD
Asenapine—Hypertension—Prednisolone—multiple sclerosis	0.000456	0.00146	CcSEcCtD
Asenapine—ADRA2A—central nervous system—multiple sclerosis	0.000454	0.00164	CbGeAlD
Asenapine—Fatigue—Mitoxantrone—multiple sclerosis	0.000453	0.00145	CcSEcCtD
Asenapine—ADRA2C—brain—multiple sclerosis	0.000451	0.00163	CbGeAlD
Asenapine—Constipation—Mitoxantrone—multiple sclerosis	0.00045	0.00144	CcSEcCtD
Asenapine—Angioedema—Triamcinolone—multiple sclerosis	0.000444	0.00143	CcSEcCtD
Asenapine—Angioedema—Methylprednisolone—multiple sclerosis	0.000443	0.00142	CcSEcCtD
Asenapine—ADRA2A—cerebellum—multiple sclerosis	0.000443	0.0016	CbGeAlD
Asenapine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000442	0.00142	CcSEcCtD
Asenapine—Malaise—Triamcinolone—multiple sclerosis	0.000438	0.00141	CcSEcCtD
Asenapine—Malaise—Methylprednisolone—multiple sclerosis	0.000438	0.0014	CcSEcCtD
Asenapine—Syncope—Triamcinolone—multiple sclerosis	0.000436	0.0014	CcSEcCtD
Asenapine—Syncope—Methylprednisolone—multiple sclerosis	0.000435	0.0014	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000434	0.00139	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000432	0.00138	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—multiple sclerosis	0.000431	0.00138	CcSEcCtD
Asenapine—Dizziness—Azathioprine—multiple sclerosis	0.00043	0.00138	CcSEcCtD
Asenapine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000427	0.00137	CcSEcCtD
Asenapine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000426	0.00137	CcSEcCtD
Asenapine—Shock—Prednisolone—multiple sclerosis	0.000425	0.00136	CcSEcCtD
Asenapine—Convulsion—Triamcinolone—multiple sclerosis	0.000421	0.00135	CcSEcCtD
Asenapine—Tachycardia—Prednisolone—multiple sclerosis	0.000421	0.00135	CcSEcCtD
Asenapine—Convulsion—Methylprednisolone—multiple sclerosis	0.00042	0.00135	CcSEcCtD
Asenapine—Hypertension—Triamcinolone—multiple sclerosis	0.00042	0.00135	CcSEcCtD
Asenapine—Hypertension—Methylprednisolone—multiple sclerosis	0.000419	0.00134	CcSEcCtD
Asenapine—Vomiting—Azathioprine—multiple sclerosis	0.000414	0.00133	CcSEcCtD
Asenapine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000413	0.00132	CcSEcCtD
Asenapine—Eye disorder—Prednisone—multiple sclerosis	0.000412	0.00132	CcSEcCtD
Asenapine—Anxiety—Methylprednisolone—multiple sclerosis	0.000412	0.00132	CcSEcCtD
Asenapine—Rash—Azathioprine—multiple sclerosis	0.00041	0.00132	CcSEcCtD
Asenapine—Dermatitis—Azathioprine—multiple sclerosis	0.00041	0.00131	CcSEcCtD
Asenapine—Depression—Methotrexate—multiple sclerosis	0.00041	0.00131	CcSEcCtD
Asenapine—Headache—Azathioprine—multiple sclerosis	0.000408	0.00131	CcSEcCtD
Asenapine—Dry mouth—Triamcinolone—multiple sclerosis	0.000405	0.0013	CcSEcCtD
Asenapine—Angioedema—Dexamethasone—multiple sclerosis	0.000403	0.00129	CcSEcCtD
Asenapine—Angioedema—Betamethasone—multiple sclerosis	0.000403	0.00129	CcSEcCtD
Asenapine—HTR2A—nervous system—multiple sclerosis	0.000401	0.00144	CbGeAlD
Asenapine—Stomatitis—Methotrexate—multiple sclerosis	0.000401	0.00128	CcSEcCtD
Asenapine—Angiopathy—Prednisone—multiple sclerosis	0.0004	0.00128	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—multiple sclerosis	0.000399	0.00128	CcSEcCtD
Asenapine—Malaise—Dexamethasone—multiple sclerosis	0.000398	0.00128	CcSEcCtD
Asenapine—Malaise—Betamethasone—multiple sclerosis	0.000398	0.00128	CcSEcCtD
Asenapine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000397	0.00127	CcSEcCtD
Asenapine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000396	0.00127	CcSEcCtD
Asenapine—Syncope—Dexamethasone—multiple sclerosis	0.000396	0.00127	CcSEcCtD
Asenapine—Syncope—Betamethasone—multiple sclerosis	0.000396	0.00127	CcSEcCtD
Asenapine—Shock—Triamcinolone—multiple sclerosis	0.00039	0.00125	CcSEcCtD
Asenapine—Insomnia—Prednisolone—multiple sclerosis	0.00039	0.00125	CcSEcCtD
Asenapine—Shock—Methylprednisolone—multiple sclerosis	0.00039	0.00125	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000389	0.00125	CcSEcCtD
Asenapine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000388	0.00125	CcSEcCtD
Asenapine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000388	0.00124	CcSEcCtD
Asenapine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000388	0.00124	CcSEcCtD
Asenapine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000388	0.00124	CcSEcCtD
Asenapine—Tachycardia—Triamcinolone—multiple sclerosis	0.000387	0.00124	CcSEcCtD
Asenapine—Mental disorder—Prednisone—multiple sclerosis	0.000387	0.00124	CcSEcCtD
Asenapine—Nausea—Azathioprine—multiple sclerosis	0.000386	0.00124	CcSEcCtD
Asenapine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000386	0.00124	CcSEcCtD
Asenapine—HTR2A—central nervous system—multiple sclerosis	0.000386	0.00139	CbGeAlD
Asenapine—Malnutrition—Prednisone—multiple sclerosis	0.000384	0.00123	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000383	0.00123	CcSEcCtD
Asenapine—Convulsion—Dexamethasone—multiple sclerosis	0.000382	0.00123	CcSEcCtD
Asenapine—Convulsion—Betamethasone—multiple sclerosis	0.000382	0.00123	CcSEcCtD
Asenapine—Hypertension—Betamethasone—multiple sclerosis	0.000381	0.00122	CcSEcCtD
Asenapine—Hypertension—Dexamethasone—multiple sclerosis	0.000381	0.00122	CcSEcCtD
Asenapine—Asthenia—Mitoxantrone—multiple sclerosis	0.000377	0.00121	CcSEcCtD
Asenapine—HTR2A—cerebellum—multiple sclerosis	0.000377	0.00136	CbGeAlD
Asenapine—Anxiety—Betamethasone—multiple sclerosis	0.000374	0.0012	CcSEcCtD
Asenapine—Anxiety—Dexamethasone—multiple sclerosis	0.000374	0.0012	CcSEcCtD
Asenapine—CYP3A4—nervous system—multiple sclerosis	0.000371	0.00134	CbGeAlD
Asenapine—Hypotension—Methylprednisolone—multiple sclerosis	0.00037	0.00119	CcSEcCtD
Asenapine—HRH1—brain—multiple sclerosis	0.000367	0.00132	CbGeAlD
Asenapine—CYP2D6—nervous system—multiple sclerosis	0.000365	0.00132	CbGeAlD
Asenapine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000362	0.00116	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000361	0.00116	CcSEcCtD
Asenapine—ADRA2A—brain—multiple sclerosis	0.00036	0.0013	CbGeAlD
Asenapine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00036	0.00115	CcSEcCtD
Asenapine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00036	0.00115	CcSEcCtD
Asenapine—Insomnia—Triamcinolone—multiple sclerosis	0.000359	0.00115	CcSEcCtD
Asenapine—Insomnia—Methylprednisolone—multiple sclerosis	0.000358	0.00115	CcSEcCtD
Asenapine—CYP3A4—central nervous system—multiple sclerosis	0.000357	0.00129	CbGeAlD
Asenapine—Anaemia—Prednisone—multiple sclerosis	0.000355	0.00114	CcSEcCtD
Asenapine—Shock—Dexamethasone—multiple sclerosis	0.000354	0.00114	CcSEcCtD
Asenapine—Shock—Betamethasone—multiple sclerosis	0.000354	0.00114	CcSEcCtD
Asenapine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000354	0.00113	CcSEcCtD
Asenapine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000353	0.00113	CcSEcCtD
Asenapine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000353	0.00113	CcSEcCtD
Asenapine—Agitation—Prednisone—multiple sclerosis	0.000353	0.00113	CcSEcCtD
Asenapine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000353	0.00113	CcSEcCtD
Asenapine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000353	0.00113	CcSEcCtD
Asenapine—Tachycardia—Dexamethasone—multiple sclerosis	0.000351	0.00113	CcSEcCtD
Asenapine—Tachycardia—Betamethasone—multiple sclerosis	0.000351	0.00113	CcSEcCtD
Asenapine—CYP2D6—central nervous system—multiple sclerosis	0.000351	0.00127	CbGeAlD
Asenapine—Angioedema—Prednisone—multiple sclerosis	0.000351	0.00113	CcSEcCtD
Asenapine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000349	0.00112	CcSEcCtD
Asenapine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000349	0.00112	CcSEcCtD
Asenapine—Malaise—Prednisone—multiple sclerosis	0.000346	0.00111	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—multiple sclerosis	0.000345	0.00111	CcSEcCtD
Asenapine—Syncope—Prednisone—multiple sclerosis	0.000345	0.00111	CcSEcCtD
Asenapine—CYP2D6—cerebellum—multiple sclerosis	0.000343	0.00124	CbGeAlD
Asenapine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000342	0.0011	CcSEcCtD
Asenapine—Fatigue—Triamcinolone—multiple sclerosis	0.000342	0.0011	CcSEcCtD
Asenapine—Fatigue—Methylprednisolone—multiple sclerosis	0.000341	0.00109	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—multiple sclerosis	0.000338	0.00108	CcSEcCtD
Asenapine—Hypotension—Betamethasone—multiple sclerosis	0.000336	0.00108	CcSEcCtD
Asenapine—Hypotension—Dexamethasone—multiple sclerosis	0.000336	0.00108	CcSEcCtD
Asenapine—Angiopathy—Methotrexate—multiple sclerosis	0.000335	0.00107	CcSEcCtD
Asenapine—Vomiting—Mitoxantrone—multiple sclerosis	0.000334	0.00107	CcSEcCtD
Asenapine—Immune system disorder—Methotrexate—multiple sclerosis	0.000333	0.00107	CcSEcCtD
Asenapine—Convulsion—Prednisone—multiple sclerosis	0.000333	0.00107	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000332	0.00107	CcSEcCtD
Asenapine—Hypertension—Prednisone—multiple sclerosis	0.000332	0.00106	CcSEcCtD
Asenapine—Rash—Mitoxantrone—multiple sclerosis	0.000332	0.00106	CcSEcCtD
Asenapine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000331	0.00106	CcSEcCtD
Asenapine—Headache—Mitoxantrone—multiple sclerosis	0.00033	0.00106	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000328	0.00105	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000328	0.00105	CcSEcCtD
Asenapine—Arthralgia—Prednisone—multiple sclerosis	0.000327	0.00105	CcSEcCtD
Asenapine—Anxiety—Prednisone—multiple sclerosis	0.000326	0.00105	CcSEcCtD
Asenapine—Insomnia—Dexamethasone—multiple sclerosis	0.000326	0.00104	CcSEcCtD
Asenapine—Insomnia—Betamethasone—multiple sclerosis	0.000326	0.00104	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—multiple sclerosis	0.000323	0.00104	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—multiple sclerosis	0.000321	0.00103	CcSEcCtD
Asenapine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000318	0.00102	CcSEcCtD
Asenapine—Dyspepsia—Betamethasone—multiple sclerosis	0.000317	0.00102	CcSEcCtD
Asenapine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000317	0.00102	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—multiple sclerosis	0.000314	0.00101	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000314	0.00101	CcSEcCtD
Asenapine—Nausea—Mitoxantrone—multiple sclerosis	0.000312	0.001	CcSEcCtD
Asenapine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000311	0.000997	CcSEcCtD
Asenapine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000311	0.000997	CcSEcCtD
Asenapine—Fatigue—Betamethasone—multiple sclerosis	0.00031	0.000996	CcSEcCtD
Asenapine—Fatigue—Dexamethasone—multiple sclerosis	0.00031	0.000996	CcSEcCtD
Asenapine—Shock—Prednisone—multiple sclerosis	0.000309	0.00099	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—multiple sclerosis	0.000308	0.000986	CcSEcCtD
Asenapine—HTR2A—brain—multiple sclerosis	0.000306	0.0011	CbGeAlD
Asenapine—Tachycardia—Prednisone—multiple sclerosis	0.000306	0.000982	CcSEcCtD
Asenapine—Anaemia—Methotrexate—multiple sclerosis	0.000297	0.000952	CcSEcCtD
Asenapine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000292	0.000938	CcSEcCtD
Asenapine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000292	0.000936	CcSEcCtD
Asenapine—Malaise—Methotrexate—multiple sclerosis	0.00029	0.000929	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—multiple sclerosis	0.000287	0.000922	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000286	0.000916	CcSEcCtD
Asenapine—Dizziness—Prednisolone—multiple sclerosis	0.000285	0.000915	CcSEcCtD
Asenapine—Asthenia—Triamcinolone—multiple sclerosis	0.000285	0.000913	CcSEcCtD
Asenapine—Asthenia—Methylprednisolone—multiple sclerosis	0.000284	0.000911	CcSEcCtD
Asenapine—Insomnia—Prednisone—multiple sclerosis	0.000284	0.00091	CcSEcCtD
Asenapine—CYP2D6—brain—multiple sclerosis	0.000279	0.00101	CbGeAlD
Asenapine—Convulsion—Methotrexate—multiple sclerosis	0.000278	0.000892	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—multiple sclerosis	0.000276	0.000885	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—multiple sclerosis	0.000273	0.000877	CcSEcCtD
Asenapine—Rash—Prednisolone—multiple sclerosis	0.000272	0.000873	CcSEcCtD
Asenapine—Dermatitis—Prednisolone—multiple sclerosis	0.000272	0.000872	CcSEcCtD
Asenapine—Fatigue—Prednisone—multiple sclerosis	0.00027	0.000867	CcSEcCtD
Asenapine—Headache—Prednisolone—multiple sclerosis	0.00027	0.000867	CcSEcCtD
Asenapine—Constipation—Prednisone—multiple sclerosis	0.000268	0.00086	CcSEcCtD
Asenapine—Dizziness—Triamcinolone—multiple sclerosis	0.000262	0.000842	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000262	0.000841	CcSEcCtD
Asenapine—Dizziness—Methylprednisolone—multiple sclerosis	0.000262	0.00084	CcSEcCtD
Asenapine—Asthenia—Dexamethasone—multiple sclerosis	0.000258	0.000829	CcSEcCtD
Asenapine—Asthenia—Betamethasone—multiple sclerosis	0.000258	0.000829	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000257	0.000824	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000257	0.000823	CcSEcCtD
Asenapine—Nausea—Prednisolone—multiple sclerosis	0.000256	0.000822	CcSEcCtD
Asenapine—Vomiting—Triamcinolone—multiple sclerosis	0.000252	0.000809	CcSEcCtD
Asenapine—Vomiting—Methylprednisolone—multiple sclerosis	0.000252	0.000808	CcSEcCtD
Asenapine—Rash—Triamcinolone—multiple sclerosis	0.00025	0.000803	CcSEcCtD
Asenapine—Dermatitis—Triamcinolone—multiple sclerosis	0.00025	0.000802	CcSEcCtD
Asenapine—Rash—Methylprednisolone—multiple sclerosis	0.00025	0.000801	CcSEcCtD
Asenapine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000249	0.0008	CcSEcCtD
Asenapine—Headache—Triamcinolone—multiple sclerosis	0.000249	0.000797	CcSEcCtD
Asenapine—Headache—Methylprednisolone—multiple sclerosis	0.000248	0.000796	CcSEcCtD
Asenapine—Hypotension—Methotrexate—multiple sclerosis	0.000245	0.000785	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000239	0.000766	CcSEcCtD
Asenapine—Dizziness—Betamethasone—multiple sclerosis	0.000238	0.000764	CcSEcCtD
Asenapine—Dizziness—Dexamethasone—multiple sclerosis	0.000238	0.000764	CcSEcCtD
Asenapine—Insomnia—Methotrexate—multiple sclerosis	0.000237	0.00076	CcSEcCtD
Asenapine—Nausea—Triamcinolone—multiple sclerosis	0.000236	0.000756	CcSEcCtD
Asenapine—Nausea—Methylprednisolone—multiple sclerosis	0.000235	0.000754	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—multiple sclerosis	0.000234	0.000749	CcSEcCtD
Asenapine—Somnolence—Methotrexate—multiple sclerosis	0.000233	0.000747	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—multiple sclerosis	0.000231	0.000741	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—multiple sclerosis	0.000231	0.00074	CcSEcCtD
Asenapine—Vomiting—Dexamethasone—multiple sclerosis	0.000229	0.000734	CcSEcCtD
Asenapine—Vomiting—Betamethasone—multiple sclerosis	0.000229	0.000734	CcSEcCtD
Asenapine—Rash—Betamethasone—multiple sclerosis	0.000227	0.000728	CcSEcCtD
Asenapine—Rash—Dexamethasone—multiple sclerosis	0.000227	0.000728	CcSEcCtD
Asenapine—Dermatitis—Betamethasone—multiple sclerosis	0.000227	0.000728	CcSEcCtD
Asenapine—Dermatitis—Dexamethasone—multiple sclerosis	0.000227	0.000728	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000226	0.000726	CcSEcCtD
Asenapine—Fatigue—Methotrexate—multiple sclerosis	0.000226	0.000725	CcSEcCtD
Asenapine—Headache—Betamethasone—multiple sclerosis	0.000226	0.000724	CcSEcCtD
Asenapine—Headache—Dexamethasone—multiple sclerosis	0.000226	0.000724	CcSEcCtD
Asenapine—Asthenia—Prednisone—multiple sclerosis	0.000225	0.000722	CcSEcCtD
Asenapine—Nausea—Betamethasone—multiple sclerosis	0.000214	0.000686	CcSEcCtD
Asenapine—Nausea—Dexamethasone—multiple sclerosis	0.000214	0.000686	CcSEcCtD
Asenapine—Dizziness—Prednisone—multiple sclerosis	0.000207	0.000665	CcSEcCtD
Asenapine—Vomiting—Prednisone—multiple sclerosis	0.000199	0.00064	CcSEcCtD
Asenapine—Rash—Prednisone—multiple sclerosis	0.000198	0.000634	CcSEcCtD
Asenapine—Dermatitis—Prednisone—multiple sclerosis	0.000198	0.000634	CcSEcCtD
Asenapine—Headache—Prednisone—multiple sclerosis	0.000196	0.00063	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000193	0.000619	CcSEcCtD
Asenapine—Asthenia—Methotrexate—multiple sclerosis	0.000188	0.000603	CcSEcCtD
Asenapine—Nausea—Prednisone—multiple sclerosis	0.000186	0.000597	CcSEcCtD
Asenapine—Dizziness—Methotrexate—multiple sclerosis	0.000173	0.000556	CcSEcCtD
Asenapine—Vomiting—Methotrexate—multiple sclerosis	0.000167	0.000534	CcSEcCtD
Asenapine—Rash—Methotrexate—multiple sclerosis	0.000165	0.00053	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—multiple sclerosis	0.000165	0.00053	CcSEcCtD
Asenapine—Headache—Methotrexate—multiple sclerosis	0.000164	0.000527	CcSEcCtD
Asenapine—Nausea—Methotrexate—multiple sclerosis	0.000156	0.000499	CcSEcCtD
Asenapine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.43e-05	5.32e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.43e-05	5.32e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—STAT3—multiple sclerosis	1.43e-05	5.31e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.43e-05	5.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.43e-05	5.3e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.42e-05	5.28e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	5.27e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	5.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.41e-05	5.24e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.41e-05	5.24e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.41e-05	5.23e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.41e-05	5.22e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	5.21e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.39e-05	5.16e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.38e-05	5.14e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.38e-05	5.13e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.38e-05	5.11e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.37e-05	5.1e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	5.07e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.36e-05	5.06e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.35e-05	5.02e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.35e-05	5.01e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.35e-05	5e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.33e-05	4.95e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	4.95e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.33e-05	4.95e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.33e-05	4.94e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	4.93e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MYC—multiple sclerosis	1.33e-05	4.93e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	1.32e-05	4.92e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.32e-05	4.91e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.31e-05	4.87e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.31e-05	4.87e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.31e-05	4.86e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.31e-05	4.86e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.3e-05	4.85e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	4.84e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	4.84e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	4.84e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	4.83e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	1.3e-05	4.82e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	4.82e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.3e-05	4.81e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.29e-05	4.81e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.29e-05	4.8e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.29e-05	4.8e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL2—multiple sclerosis	1.29e-05	4.8e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	1.29e-05	4.77e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.28e-05	4.77e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.28e-05	4.76e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.28e-05	4.74e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.28e-05	4.74e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	4.71e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL2—multiple sclerosis	1.27e-05	4.7e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.26e-05	4.68e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	1.26e-05	4.68e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.25e-05	4.63e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL2—multiple sclerosis	1.24e-05	4.62e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	4.61e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	1.24e-05	4.6e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.23e-05	4.58e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	4.58e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	4.57e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.23e-05	4.55e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	1.22e-05	4.54e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.21e-05	4.5e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	4.48e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	4.47e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.2e-05	4.46e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	1.2e-05	4.45e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.19e-05	4.43e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	4.41e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.19e-05	4.4e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	4.4e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.18e-05	4.39e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.18e-05	4.39e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.18e-05	4.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.16e-05	4.31e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	4.3e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	4.28e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	4.25e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.13e-05	4.18e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.12e-05	4.18e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.12e-05	4.17e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.12e-05	4.16e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.12e-05	4.16e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—multiple sclerosis	1.12e-05	4.16e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	4.16e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.12e-05	4.15e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.12e-05	4.14e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.11e-05	4.11e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.1e-05	4.1e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	4.09e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.1e-05	4.09e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	4.08e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.1e-05	4.07e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.1e-05	4.07e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.09e-05	4.06e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	1.09e-05	4.04e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.08e-05	4.01e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.08e-05	4e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	4e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	4e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	1.06e-05	3.95e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.06e-05	3.94e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.06e-05	3.92e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	1.05e-05	3.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.05e-05	3.89e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.02e-05	3.81e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.78e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.02e-05	3.78e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.78e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	1.02e-05	3.77e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	3.77e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MYC—multiple sclerosis	1.01e-05	3.75e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.01e-05	3.75e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	3.74e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2—multiple sclerosis	1.01e-05	3.74e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	1e-05	3.72e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1e-05	3.72e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1e-05	3.72e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1e-05	3.71e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	9.98e-06	3.71e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	9.98e-06	3.71e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—multiple sclerosis	9.98e-06	3.71e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	9.96e-06	3.7e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	9.95e-06	3.69e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	9.93e-06	3.69e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MYC—multiple sclerosis	9.89e-06	3.67e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	9.88e-06	3.67e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	9.87e-06	3.67e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	9.86e-06	3.66e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.81e-06	3.64e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	9.81e-06	3.64e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	9.8e-06	3.64e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MYC—multiple sclerosis	9.73e-06	3.62e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	9.71e-06	3.61e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	9.68e-06	3.59e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	9.64e-06	3.58e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	9.59e-06	3.56e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	9.59e-06	3.56e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	9.54e-06	3.54e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	9.54e-06	3.54e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	9.52e-06	3.54e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	9.45e-06	3.51e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	9.43e-06	3.5e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	9.33e-06	3.46e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	9.32e-06	3.46e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	9.3e-06	3.46e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—multiple sclerosis	9.29e-06	3.45e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	9.29e-06	3.45e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	9.28e-06	3.45e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	9.27e-06	3.44e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	9.12e-06	3.39e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	9.1e-06	3.38e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	9.09e-06	3.38e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	9.07e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	8.83e-06	3.28e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—multiple sclerosis	8.76e-06	3.25e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.74e-06	3.25e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—multiple sclerosis	8.65e-06	3.21e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	8.62e-06	3.2e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	8.57e-06	3.18e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	8.48e-06	3.15e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—multiple sclerosis	8.46e-06	3.14e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	8.46e-06	3.14e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	8.42e-06	3.13e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	8.4e-06	3.12e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	8.33e-06	3.09e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—multiple sclerosis	8.31e-06	3.09e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	8.29e-06	3.08e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	8.28e-06	3.08e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	8.27e-06	3.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	8.15e-06	3.03e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	8.11e-06	3.01e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	8.11e-06	3.01e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	8.07e-06	3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.01e-06	2.97e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—POMC—multiple sclerosis	7.98e-06	2.97e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	7.88e-06	2.93e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—multiple sclerosis	7.88e-06	2.93e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.87e-06	2.92e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	7.86e-06	2.92e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	7.86e-06	2.92e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	7.85e-06	2.91e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	7.81e-06	2.9e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	7.79e-06	2.89e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	7.72e-06	2.87e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	7.71e-06	2.86e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	7.71e-06	2.86e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	7.69e-06	2.86e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—multiple sclerosis	7.65e-06	2.84e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—multiple sclerosis	7.64e-06	2.84e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	7.64e-06	2.84e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—multiple sclerosis	7.59e-06	2.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	7.57e-06	2.81e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	7.54e-06	2.8e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	7.54e-06	2.8e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	7.54e-06	2.8e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	7.52e-06	2.79e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	7.5e-06	2.78e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	7.48e-06	2.78e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—multiple sclerosis	7.44e-06	2.76e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	7.37e-06	2.74e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	7.33e-06	2.72e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—multiple sclerosis	7.32e-06	2.72e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	7.29e-06	2.71e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—multiple sclerosis	7.28e-06	2.7e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	7.27e-06	2.7e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	7.17e-06	2.66e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	7.13e-06	2.65e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.12e-06	2.64e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	7.01e-06	2.6e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	6.99e-06	2.6e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	6.98e-06	2.59e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	6.86e-06	2.55e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.76e-06	2.51e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.62e-06	2.46e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.6e-06	2.45e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—multiple sclerosis	6.59e-06	2.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	6.51e-06	2.42e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—multiple sclerosis	6.5e-06	2.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—multiple sclerosis	6.5e-06	2.41e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	6.49e-06	2.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	6.48e-06	2.41e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	6.47e-06	2.4e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	6.37e-06	2.37e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	6.37e-06	2.37e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	6.37e-06	2.37e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	6.36e-06	2.36e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	6.35e-06	2.36e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	6.24e-06	2.32e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.17e-06	2.29e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.08e-06	2.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.92e-06	2.2e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—multiple sclerosis	5.92e-06	2.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.91e-06	2.19e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	5.87e-06	2.18e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.79e-06	2.15e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	5.79e-06	2.15e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.66e-06	2.1e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	5.64e-06	2.09e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	5.48e-06	2.04e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.22e-06	1.94e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.97e-06	1.85e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.89e-06	1.82e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—multiple sclerosis	4.88e-06	1.81e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.79e-06	1.78e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.76e-06	1.77e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.45e-06	1.65e-05	CbGpPWpGaD
